Immunotherapeutic Strategies in the Management of Osteosarcoma
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by Fortune Journals in Journal of Orthopaedics and Sports Medicine
- Vol. 05 (01) , 32-40
Abstract
Osteosarcoma (OS) is the most common primary malignant bone cancer with a high tendency for metastasis. Although treatment strategies involving surgery and chemotherapy have improved outcomes for patients with OS, the prognosis of recurrent OS is quite unsatisfactory. Primary reasons leading to mortality in OS patients are resistance to currently used therapies and the subsequent lung metastasis. Immunotherapy, however, has been shown to be a promising therapeutic strategy against OS. As research progresses, immunotherapy is gradually becoming irreplaceable. This article provides a critical evaluation of several therapeutic strategies for OS including immunomodulation, vaccine therapy, and immunologic checkpoint blockade.Keywords
This publication has 82 references indexed in Scilit:
- Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 MacrophagesPLOS ONE, 2013
- Effect of the cytokine levels in serum on osteosarcomaTumor Biology, 2013
- Macrophage plasticity and polarization: in vivo veritasJournal of Clinical Investigation, 2012
- Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cellsCancer Immunology, Immunotherapy, 2011
- Addition of pamidronate to chemotherapy for the treatment of osteosarcomaCancer, 2010
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen ExpressionMolecular Therapy, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Cancer-related inflammationNature, 2008
- Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcomaCancer Science, 2008
- Vaccine Trials for Osteogenic Sarcoma: A Preliminary ReportCA: A Cancer Journal for Clinicians, 1973